Healios KK

46
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3835100003
JPY
393.00
28 (7.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Healios KK Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-2,124.00
-4,059.00
-3,628.00
-5,333.00
-4,459.00
-5,364.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-64.00
762.00
251.00
281.00
120.00
89.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-3,165.00
-1,817.00
-2,822.00
-4,601.00
-5,089.00
-3,945.00
Cash Flow from Investing Activities
-1,114.00
-1,418.00
-1,112.00
-909.00
-736.00
-1,216.00
Cash Flow from Financing Activities
6,335.00
77.00
3,328.00
-2,502.00
6,988.00
803.00
Net Cash Inflow / Outflow
2,007.00
-3,050.00
-524.00
-7,879.00
1,203.00
-4,371.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-49.00
108.00
82.00
133.00
40.00
-13.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Healios KK
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-2124
958
-3,082.00
-321.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-64
94
-158.00
-168.09%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-3165
814
-3,979.00
-488.82%
Cash Flow from Investing Activities
-1114
142
-1,256.00
-884.51%
Cash Flow from Financing Activities
6335
-1227
7,562.00
616.30%
Net Cash Inflow / Outflow
2007
-276
2,283.00
827.17%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-49
-5
-44.00
-880.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -74.19% vs 35.61% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-3,165.00
-1,817.00
-74.19%